Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

NCT00004884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: cisplatin
DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC